SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,542.44 43.27
( 0.06%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

66,870.65 1,263.94
(1.93%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Unjha Formulations Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531762

INE576D01015

8.5780605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.1

10.87

EPS(TTM)

Face Value()

Div & Yield %

1.05

Back

Unjha Formulations standalone net profit declines 58.97% in the June 2026 quarter

Aug 03,2026

Net profit of Unjha Formulations declined 58.97% to Rs 0.16 crore in the quarter ended June 2026 as against Rs 0.39 crore during the previous quarter ended June 2025. Sales declined 8.31% to Rs 3.31 crore in the quarter ended June 2026 as against Rs 3.61 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3.31	3.61	-8
OPM %	6.04	11.63	-
PBDT	0.20	0.42	-52
PBT	0.16	0.39	-59
NP	0.16	0.39	-59

78,542.44 43.27 ( 0.06%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

66,870.65 1,263.94 (1.93%)

10,909.12 41.23 (0.38%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)